Ascent Group’s Organon & Co OGN Stock Holding History

Ascent Group’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,122	Closed	-$204K	–	787
2025 Q3	$204K	Buy	+19,122	New	+$188K	0.01%	712
2025 Q2	–	Sell	-10,126	Closed	-$151K	–	749
2025 Q1	$151K	Buy	+10,126	New	+$156K	0.01%	675

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Ascent Group's OGN Position: Q4 2025 in Review

Ascent Group sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 19,122 shares — an estimated $204K sold.

Ascent Group first reported a position in OGN in Q1 2025 and held it in 2 quarters. The position peaked at $204K in Q3 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

Ascent Group reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
Ascent Group sold 19,122 Organon & Co shares in Q4 2025, an estimated $204K.
Ascent Group first reported a position in Organon & Co in Q1 2025 and held it in 2 quarters.
Ascent Group's Organon & Co position peaked at $204K in Q3 2025.
631 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Ascent Group's 13F filing for Q4 2025, filed 20 Jan 2026.